Evaluate the Safety and Efficacy of Toripalimab Combined With Bevacizumab Versus Sorafenib Therapy for HCC
Clinical trial NCT04723004 · COMPLETED
Trial details
- NCT number
- NCT04723004
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2024-05-31
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.